Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Cancer Research Institute
May 26, 2024, 06:31 |
Insight
Vivek Subbiah: Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma
Vivek Subbiah shared a post on X/Twitter: "Impressive response to dabrafenib, trametinib, and osimertinib in a…
May 26, 2024, 06:02 |
Insight
Toni Choueiri: The work of Eddy Saad, Eli Van Allen, Sasha Gusev being highlighted here at ASCO24
Toni Choueiri shared a post by Neeraj Agarwal on X/Twitter: "The work of Eddy Saad, Eli Van…
May 25, 2024, 15:35 |
Blog
'After my experience as a carer for my husband and father, I was motivated to give back' - Sharon Bennett
Tracey O'Brien shared a post by Cancer Institute NSW on LinkedIn: "I’m proud to work in…
May 25, 2024, 15:15 |
Blog
Paolo Tarantino: I’m extremely excited to support Giuseppe Curigliano for the next ESMO Presidential Elections
Paolo Tarantino shared on LinkedIn: "I’m extremely excited to support Giuseppe Curigliano for the next ESMO…
May 25, 2024, 14:28 |
Blog
Studies conducted by Dana-Farber at this year’s AACR Annual Meeting
Dana-Farber Cancer Institute shared on LinkedIn: "Numerous studies conducted by Dana-Farber researchers show promising results for…
May 25, 2024, 14:20 |
Blog
Marc Machaalani: Immunotherapy rechallenge after prior immune checkpoint inhibition in mRCC
Marc Machaalani, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post by ASCO on…
May 25, 2024, 13:52 |
Blog
Dr. Kelly Meza-Capcha was accepted into the ASH Minority Resident Hematology Award Program
Kelly Meza, Research assistant at Dana-Farber Cancer Institute, shared a post by BCM Department of Medicine on…
May 25, 2024, 12:41 |
Insight
Vivek Subbiah: KRAS inhibitors are here to stay
Vivek Subbiah shared on X: “KRAS inhibitors are here ASCO24 & here to stay for all…
May 25, 2024, 11:59 |
Blog
Vivek Subbiah: ASCO 24 time to learn the latest and greatest in Tissue Agnostic Precision Medicine
Vivek Subbiah shared on X: “It's ASCO 24 time Mark your calendars to learn the latest…
May 25, 2024, 11:37 |
Cancer Types
Glucagonoma: What patients should know about
What is Glucagonoma? Glucagonoma is a rare neuroendocrine tumor that originates from the pancreatic alpha…
246
247
248
249
250
All:
3200
Posts:
2471 - 2480
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube